Eagle Pharmaceuticals Inc
(EGRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,722 | -5,619 | -2,684 | -3,255 | N/A |
| Depreciation Amortization | 73 | 51 | 29 | 31 | N/A |
| Accounts receivable | -704 | -120 | -1,228 | -1,468 | N/A |
| Accounts payable and accrued liabilities | 1,713 | 174 | 112 | 1,154 | N/A |
| Other Working Capital | -128 | -1,857 | 61 | 2,978 | N/A |
| Other Operating Activity | -98 | 633 | 1,639 | 583 | 0 |
| Operating Cash Flow | $-13,866 | $-6,738 | $-2,071 | $23 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -19,999 | 0 | N/A | N/A | N/A |
| PPE Investments | -39 | -32 | -28 | -7 | N/A |
| Investing Cash Flow | $-20,038 | $-32 | $-28 | $-7 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 46,632 | 46,567 | 46,985 | N/A | N/A |
| Other Financing Activity | 20 | 20 | 20 | -498 | 0 |
| Financing Cash Flow | $46,652 | $46,587 | $47,005 | $-498 | $N/A |
| Beginning Cash Position | 9,974 | 9,974 | 9,974 | 10,456 | N/A |
| End Cash Position | 22,722 | 49,791 | 54,880 | 9,974 | N/A |
| Net Cash Flow | $12,748 | $39,817 | $44,906 | $-482 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,866 | -6,738 | -2,071 | 23 | N/A |
| Capital Expenditure | -39 | -32 | -28 | -7 | N/A |
| Free Cash Flow | -13,905 | -6,770 | -2,099 | 16 | 0 |